Prexton Therapeutics' Series B Round

Prexton Therapeutics raised a round of funding on February 07, 2017.

Prexton Therapeutics is a biopharmaceutical company which applies a new scientific approach that fully integrates molecular, behavioral and chemistry technologies to address Parkinson's disease and ot…

Articles about Prexton Therapeutics' Series B Round: